EGFR and lung carcinoma: We further investigated the dynamic levels of KRAS and EGFR mutations in plasma collected from lung cancer patients during surgery, and analyzed the quantitative relationship of KRAS and EGFR mutations in the plasma with cfDNA, as well as the correlation of cfDNA levels with the recurrence of lung cancer after surgery.